• VaxInnate Corp., of Cranbury, N.J., named Thomas Hofstaetter president and CEO, and Alan Shaw, who previously held that position, has assumed the newly created role of chief scientific officer and becomes board chairman. Prior to joining VaxInnate, Hofstaetter was senior vice president of corporate business development at Wyeth, where he also headed global business development for the company's pharmaceutical division.

In other appointments:

• Caris Life Sciences Inc., of Irving, Texas, named Dan Sawyers senior vice president and chief accounting officer, and Greg Kelly senior vice president of operations.

• Organovo Inc., of San Diego, appointed Marie Csete executive vice president of research and development.

• PharmaNet Development Group Inc., of Princeton, N.J., appointed Marc Kamin vice president of medical and scientific affairs, neuroscience.

• Prosensa, of Leiden, the Neitherlands, appointed Berndt Modig as chief financial officer.

• Valeritas Inc., of Bridgewater, N.J., hired James E. Dentzer as chief financial officer.